Zhi Sheng Chen

Zhi Sheng Chen

Chief Executive Officer at WUXI BIOLOGICS (CAYMAN) INC.

Net worth: 115 M $ as of 2026-05-30

54 year
Health Technology
Commercial Services
Consumer Services

Profile

Dr. Zhi Sheng Chen is a Chief Executive Officer & Executive Director at Wuxi Biologics (Cayman), Inc. and a Chairman at Shanghai Yaoming Haide Biotechnology Co., Ltd. He is on the Board of Directors at International Society for Pharmaceutical Engineering and Wuxi Biologics (Cayman), Inc. Dr. Chen was previously employed as a Chief Operating Officer by Shanghai Celgen Bio-pharmaceutical Co., Ltd., a Manager by Merck & Co., Inc., a Director-Process Science & Production by Eli Lilly Asia, Inc., a Chief Executive Officer by Kanda Biotech Holdings Ltd., and a Chief Executive Officer & Director by WuXi AppTec Co., Ltd. He also served on the board at Eli Lilly & Co. He received his undergraduate degree from Tsinghua University and a doctorate degree from the University of Delaware.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-26 18,472,892 ( 0.45% ) 79 M $ 2026-05-30
9.92%
2026-04-09 9,300,000 ( 9.92% ) 33 M $ 2026-05-30
2025-12-30 415,636 ( 0.03% ) 3 M $ 2026-05-30

Zhi Sheng Chen active positions

CompaniesPositionStart
WUXI BIOLOGICS (CAYMAN) INC. Chief Executive Officer 2015-12-31
WUXI XDC CAYMAN INC. Chairman 2020-11-30
Director/Board Member 2018-11-06
Chairman -
Chairman -

Former positions of Zhi Sheng Chen

CompaniesPositionEnd
Corporate Officer/Principal 2015-12-31
Chief Operating Officer 2011-05-31
ELI LILLY AND COMPANY Director/Board Member 2008-07-31
MERCK & CO., INC. Corporate Officer/Principal 2005-10-31
░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
See the detail of Zhi Sheng Chen's experience

Training of Zhi Sheng Chen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

92

1st degree connections

15

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies15

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Eli Lilly Asia, Inc.

Finance

Health Technology

Health Technology

Commercial Services

Distribution Services

Commercial Services

  1. Stock Market
  2. Insiders
  3. Zhi Sheng Chen
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!